May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference



April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates


Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates


Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall


FDA MedWatch Class I Recall 4 18 14



Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

FDA Recognizes ASA for Surgical Fire Prevention Efforts

Monday, August 27, 2012

The Food and Drug Administration (FDA) selected ASA to receive the "Group Recognition Award for superior achievement of the Agency’s mission through teamwork, partnership, shared responsibility or collaboration to achieve FDA goals." 

The FDA pointed out ASA’s leadership in launching the "Preventing Surgical Fires Initiative" as part of the FDA’s Safe Use Initiative. ASA’s efforts were instrumental in "increasing surgical personnel awareness of factors that contribute to surgical fires, disseminating surgical fire prevention tools and promoting the adoption of risk reduction practices throughout the healthcare community."

The award is a testament to ASA’s continued strive to improve patient safety.  ASA thanks members participating in this important initiative.      

Review the award letter.

Learn more about the Preventing Surgical Fires Initiative.

« Back to Washington Alerts